Sanofi-Aventis Menactra Approved; Launch Awaits ACIP Recommendations

Sanofi-Aventis' launch of its meningococcal conjugate vaccine Menactra will await formal recommendations for use by the Centers for Disease Control & Prevention's Advisory Committee on Immunization Practices next month